AB
Araceli Biosciences Inc.
SEC filingOther Technology · Tigard, OR
Amount raised$12.2Msold at filing
Total offering$14.1M$1.8M still open
Investors in the raise28count reported to the SEC
FiledDec 9, 2025first sale Dec 31, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Matt BeaudetExecutive Officer, Director
Kirk MalloyDirector
Sean O'NeillDirector
Shawn MacDonaldExecutive Officer
Samraat RahaDirector
Kevin GabeleinDirector
J. William FreytagDirector
William CortelyouDirector
Bruce RhineDirector
Executive officers, directors and promoters as listed on the Form D.